-
1
-
-
0036838224
-
Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults
-
Barbour J., Wrin T., Grant R., Martin J., Segal M., Petropoulos C., and Deeks S. Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults. J. Virol. 76 21 (2002) 11104-11112
-
(2002)
J. Virol.
, vol.76
, Issue.21
, pp. 11104-11112
-
-
Barbour, J.1
Wrin, T.2
Grant, R.3
Martin, J.4
Segal, M.5
Petropoulos, C.6
Deeks, S.7
-
2
-
-
0036964474
-
Approximate Bayesian computation in population genetics
-
Beaumont M., Zhang W., and Balding D. Approximate Bayesian computation in population genetics. Genetics 162 4 (2002) 2025-2035
-
(2002)
Genetics
, vol.162
, Issue.4
, pp. 2025-2035
-
-
Beaumont, M.1
Zhang, W.2
Balding, D.3
-
3
-
-
62749200513
-
Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance
-
Update
-
Bennett D., Camacho R., Otelea D., Kuritzkes D., Fleury H., Kiuchi M., Heneine W., Kantor R., Jordan M., Schapiro J., et al. Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance. PLoS ONE 4 3 (2009) Update
-
(2009)
PLoS ONE
, vol.4
, Issue.3
-
-
Bennett, D.1
Camacho, R.2
Otelea, D.3
Kuritzkes, D.4
Fleury, H.5
Kiuchi, M.6
Heneine, W.7
Kantor, R.8
Jordan, M.9
Schapiro, J.10
-
4
-
-
9444282038
-
Evidence for positive epistasis in HIV-1
-
Bonhoeffer S., Chappey C., Parkin N., Whitcomb J., and Petropoulos C. Evidence for positive epistasis in HIV-1. Science 306 5701 (2004) 1547-1550
-
(2004)
Science
, vol.306
, Issue.5701
, pp. 1547-1550
-
-
Bonhoeffer, S.1
Chappey, C.2
Parkin, N.3
Whitcomb, J.4
Petropoulos, C.5
-
5
-
-
20444406724
-
The ade4 package-I: one-table methods
-
Chessel D., Dufour A.B., and Thioulouse J. The ade4 package-I: one-table methods. R News 4 1 (2004) 5-10
-
(2004)
R News
, vol.4
, Issue.1
, pp. 5-10
-
-
Chessel, D.1
Dufour, A.B.2
Thioulouse, J.3
-
6
-
-
20644445015
-
HIV-1 pol replication capacity predicts disease progression
-
Daar E., Kesler K., Wrin T., Petropoulo C., Bates M., Lail A., Hellmann N., Gomperts E., Donfield S., et al. HIV-1 pol replication capacity predicts disease progression. Aids 19 9 (2005) 871
-
(2005)
Aids
, vol.19
, Issue.9
, pp. 871
-
-
Daar, E.1
Kesler, K.2
Wrin, T.3
Petropoulo, C.4
Bates, M.5
Lail, A.6
Hellmann, N.7
Gomperts, E.8
Donfield, S.9
-
8
-
-
33745158662
-
Evaluation of a multiple-cycle, recombinant virus, growth competition assay that uses flow cytometry to measure replication efficiency of human immunodeficiency virus type 1 in cell culture
-
Dykes C., Wang J., Jin X., Planelles V., An D., Tallo A., Huang Y., Wu H., and Demeter L. Evaluation of a multiple-cycle, recombinant virus, growth competition assay that uses flow cytometry to measure replication efficiency of human immunodeficiency virus type 1 in cell culture. J. Clin. Microbiol. 44 6 (2006) 1930
-
(2006)
J. Clin. Microbiol.
, vol.44
, Issue.6
, pp. 1930
-
-
Dykes, C.1
Wang, J.2
Jin, X.3
Planelles, V.4
An, D.5
Tallo, A.6
Huang, Y.7
Wu, H.8
Demeter, L.9
-
9
-
-
9844238154
-
Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study
-
Egger M., Hirschel B., Francioli P., Sudre P., Wirz M., Flepp M., Rickenbach M., Malinverni R., Vernazza P., and Battegay M. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Br. Med. J. 315 7117 (1997) 1194-1199
-
(1997)
Br. Med. J.
, vol.315
, Issue.7117
, pp. 1194-1199
-
-
Egger, M.1
Hirschel, B.2
Francioli, P.3
Sudre, P.4
Wirz, M.5
Flepp, M.6
Rickenbach, M.7
Malinverni, R.8
Vernazza, P.9
Battegay, M.10
-
10
-
-
77956887176
-
The biplot graphic display of matrices with application to principal component analysis
-
Gabriel K. The biplot graphic display of matrices with application to principal component analysis. Biometrika 58 3 (1971) 453-467
-
(1971)
Biometrika
, vol.58
, Issue.3
, pp. 453-467
-
-
Gabriel, K.1
-
13
-
-
10144244674
-
A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter
-
Hammer S., Katzenstein D., Hughes M., Gundacker H., Schooley R., Haubrich R., Henry W., Lederman M., Phair J., Niu M., et al. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. N. Engl. J. Med. 335 15 (1996) 1081-1090
-
(1996)
N. Engl. J. Med.
, vol.335
, Issue.15
, pp. 1081-1090
-
-
Hammer, S.1
Katzenstein, D.2
Hughes, M.3
Gundacker, H.4
Schooley, R.5
Haubrich, R.6
Henry, W.7
Lederman, M.8
Phair, J.9
Niu, M.10
-
14
-
-
48949097660
-
Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel
-
Hammer S., Eron Jr. J., Reiss P., Schooley R., Thompson M., Walmsley S., Cahn P., Fischl M., Gatell J., Hirsch M., et al. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA 300 5 (2008) 555
-
(2008)
JAMA
, vol.300
, Issue.5
, pp. 555
-
-
Hammer, S.1
Eron Jr., J.2
Reiss, P.3
Schooley, R.4
Thompson, M.5
Walmsley, S.6
Cahn, P.7
Fischl, M.8
Gatell, J.9
Hirsch, M.10
-
15
-
-
0036174444
-
Extent of cross-resistance between agents used to treat human immunodeficiency virus type 1 infection in clinically derived isolates
-
Harrigan P., and Larder B. Extent of cross-resistance between agents used to treat human immunodeficiency virus type 1 infection in clinically derived isolates. Antimicrob. Agents Chemother. 46 3 (2002) 909-912
-
(2002)
Antimicrob. Agents Chemother.
, vol.46
, Issue.3
, pp. 909-912
-
-
Harrigan, P.1
Larder, B.2
-
17
-
-
48449093709
-
Modeling and estimation of kinetic parameters and replicative fitness of HIV-1 from flow-cytometry-based growth competition experiments
-
Miao H., Dykes C., Demeter L., Cavenaugh J., Park S., Perelson A., and Wu H. Modeling and estimation of kinetic parameters and replicative fitness of HIV-1 from flow-cytometry-based growth competition experiments. Bull. Math. Biol. 70 6 (2008) 1749-1771
-
(2008)
Bull. Math. Biol.
, vol.70
, Issue.6
, pp. 1749-1771
-
-
Miao, H.1
Dykes, C.2
Demeter, L.3
Cavenaugh, J.4
Park, S.5
Perelson, A.6
Wu, H.7
-
18
-
-
0032576426
-
Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group
-
Mocroft A., Vella S., Benfield T., Chiesi A., Miller V., Gargalianos P., d'Arminio M., Yust I., Bruun J., Phillips A., et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 352 9142 (1998) 1725
-
(1998)
Lancet
, vol.352
, Issue.9142
, pp. 1725
-
-
Mocroft, A.1
Vella, S.2
Benfield, T.3
Chiesi, A.4
Miller, V.5
Gargalianos, P.6
d'Arminio, M.7
Yust, I.8
Bruun, J.9
Phillips, A.10
-
19
-
-
2642709177
-
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
-
Palella F., Delaney K., Moorman A., Loveless M., Fuhrer J., Satten G., Aschman D., and Holmberg S. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 338 13 (1998) 853-860
-
(1998)
N. Engl. J. Med.
, vol.338
, Issue.13
, pp. 853-860
-
-
Palella, F.1
Delaney, K.2
Moorman, A.3
Loveless, M.4
Fuhrer, J.5
Satten, G.6
Aschman, D.7
Holmberg, S.8
-
20
-
-
0034019566
-
A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1
-
Petropoulos C., Parkin N., Limoli K., Lie Y., Wrin T., Huang W., Tian H., Smith D., Winslow G., Capon D., et al. A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1. Antimicrob. Agents Chemother. 44 4 (2000) 920
-
(2000)
Antimicrob. Agents Chemother.
, vol.44
, Issue.4
, pp. 920
-
-
Petropoulos, C.1
Parkin, N.2
Limoli, K.3
Lie, Y.4
Wrin, T.5
Huang, W.6
Tian, H.7
Smith, D.8
Winslow, G.9
Capon, D.10
-
21
-
-
58149466150
-
ACTG 5202: shorter time to virologic failure (VF) with abacavir/lamivudine (ABC/3TC) than tenofovir/emtricitabine (TDF/FTC) as part of combination therapy in treatment-naive subjects with screening HIV RNA=100,000 c/mL
-
Sax P., Tierney C., Collier A., Fischl M., Godfrey C., Jahed N., et al. ACTG 5202: shorter time to virologic failure (VF) with abacavir/lamivudine (ABC/3TC) than tenofovir/emtricitabine (TDF/FTC) as part of combination therapy in treatment-naive subjects with screening HIV RNA=100,000 c/mL. Program and abstracts of the 17th International AIDS Conference (2008) 3-8
-
(2008)
Program and abstracts of the 17th International AIDS Conference
, pp. 3-8
-
-
Sax, P.1
Tierney, C.2
Collier, A.3
Fischl, M.4
Godfrey, C.5
Jahed, N.6
-
22
-
-
0344825778
-
Multiple effects of the M184V resistance mutation in the reverse transcriptase of human immunodeficiency virus type
-
Turner D., Brenner B., and Wainberg M. Multiple effects of the M184V resistance mutation in the reverse transcriptase of human immunodeficiency virus type. Clin. Vaccine Immunol. (2003) 979-981
-
(2003)
Clin. Vaccine Immunol.
, pp. 979-981
-
-
Turner, D.1
Brenner, B.2
Wainberg, M.3
-
23
-
-
0036839746
-
Molecular mechanisms of resistance to human immunodeficiency virus type 1 with reverse transcriptase mutations K65R and K65R + M184V and their effects on enzyme function and viral replication capacity
-
White K., Margot N., Wrin T., Petropoulos C., Miller M., and Naeger L. Molecular mechanisms of resistance to human immunodeficiency virus type 1 with reverse transcriptase mutations K65R and K65R + M184V and their effects on enzyme function and viral replication capacity. Antimicrob. Agents Chemother. 46 11 (2002) 3437
-
(2002)
Antimicrob. Agents Chemother.
, vol.46
, Issue.11
, pp. 3437
-
-
White, K.1
Margot, N.2
Wrin, T.3
Petropoulos, C.4
Miller, M.5
Naeger, L.6
-
24
-
-
77953686498
-
-
Gentleman, R, Biocore, Geneplotter: Graphics related functions for Bioconductor, r package version 1.18.0
-
Gentleman, R., Biocore, Geneplotter: Graphics related functions for Bioconductor, r package version 1.18.0.
-
-
-
|